Europe Pharmacogenetics Testing in Psychiatry/Depression Market – Industry Trends and Forecast to 2029

Customize Your Report Customize Your Report Buy Now Buy Now Free Sample Report Free Sample Report
back-icon

Back to Report
Home Medical Devices Europe Pharmacogenetic Testing In Psychiatry Depression Market Table of Content
Request for TOC Request for TOC Speak to Analyst Speak to Analyst Free Sample Report Free Sample Report Inquire Before Buying Inquire Before Buy Now Buy Now

Europe Pharmacogenetics Testing in Psychiatry/Depression Market – Industry Trends and Forecast to 2029

  • Medical Devices
  • Published Report
  • Sep 2022
  • Europe
  • 350 Pages
  • No of Tables: 405
  • No of Figures: 47
Buy Now Buy Now Request for Sample Request for Sample
Nucleus Nucleus

Table of Content

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW of Europe pharmacogenetic testing in psychiatry/depression market
    4. LIMITATIONs
    5. MARKETS COVERED
  2. MARKET SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. currency and pricing
    5. DBMR TRIPOD DATA VALIDATION MODEL
    6. MULTIVARIATE MODELLING
    7. type LIFELINE CURVE
    8. primary interviews with key opinion leaders
    9. DBMR MARKET POSITION GRID
    10. market application coverage grid
    11. vendor share analysis
    12. secondary sourcEs
    13. assumptions
  3. EXECUTIVE SUMMARY
  4. premium insights
  5. REGULATIONS: EUROPE PHARMACOGENETIC TESTING IN PSYCHIATRY/DEPRESSION MARKET
    1. EUROPEAN UNION
    2. FRANCE
  6. market overview
    1. drivers
      1. RISING NUMBER OF POPULATION SUFFERING FROM DEPRESSIVE DISORDER
      2. INITIATIVES TAKEN BY MANUFACTURERS
      3. GROWING BIOTECHNOLOGY SECTOR ALONG WITH RISING HEALTHCARE EXPENDITURE
      4. INCREASING INTEREST FOR PERSONALIZED AND PRECISION MEDICATION
      5. GROWING MEDICAL TOURISM
    2. RESTRAINTS
      1. LACK OF STRONG CLINICAL EVIDENCE
      2. HIGH COST
      3. LACK OF REIMBURSEMENT
    3. OPPORTUNITIES
      1. TECHNOLOGICAL ADVANCEMENTS
      2. EMERGENCE OF NEW PLAYERS
      3. Untapped market
    4. CHALLENGES
      1. STRINGENT GOVERNMENT REGULATION
      2. SHORTAGE OF SKILLED PERSONNEL
  7. COVID-19 IMPACT ON EUROPE PHARMACOGENETIC TESTING IN PSYCHIATRY/DEPRESSION MARKET
    1. IMPACT ON PRICE
    2. IMPACT ON DEMAND
    3. IMPACT ON SUPPLY
    4. KEY INITIATIVES BY MARKET PLAYER DURING COVID 19
    5. CONCLUSION:
  8. EUROPE PHARMACOGENETIC TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TYPE
    1. overview
    2. WHOLE GENOME SEQUENCING
    3. array-based TESTS
  9. EUROPE PHARMACOGENETIC TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY GENES
    1. overview
    2. cyp2c19
    3. CYP2C9 and VKORC1
    4. cyp2d6
    5. HLA-B
    6. htr2a/c
    7. HLA-A
    8. cyp3A4
    9. slc6a4
    10. MTHFR
    11. COMT
    12. others
  10. EUROPE PHARMACOGENETIC TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY DRUG TYPE
    1. overview
    2. PRESCRIPTION DRUGS
    3. Over-the-counter medications
    4. RECREATIONAL DRUGS
    5. VITAMINS/NUTRACEUTICals
  11. EUROPE PHARMACOGENETIC TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY SAMPLE TYPE
    1. overview
    2. SALIVA
    3. BLOOD
  12. EUROPE PHARMACOGENETIC TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY application
    1. overview
    2. DRUG DEVELOPMENT
    3. CLINICAL PRACTICE
  13. EUROPE PHARMACOGENETIC TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER
    1. overview
    2. pharmaceutical and biotechnology companies
    3. HEALTHCARE PROVIDERS
    4. research centers and academic institutes
    5. others
  14. EUROPE PHARMACOGENETIC TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY DISTRIBUTION CHANNEL
    1. overview
    2. RETAIL PHARMACIES
    3. HOSPITAL PHARMACIES
    4. MAIL-ORDER PHARMACIES
    5. DIRECt-to-customer services
  15. EUROPE PHARMACOGENETIC TESTING IN PSYCHIATRY/DEPRESSION MARKET, by Country
    1. u.k.
    2. germany
    3. france
    4. italy
    5. spain
    6. netherlands
    7. belgium
    8. russia
    9. switzerland
    10. turkey
    11. rest of Europe
  16. Europe pharmacogenetic testing in psychiatry/depression market: COMPANY landscape
    1. company share analysis: Europe
  17. swot analysis
  18. company profile
    1. MYRIAD GENETICS, INC.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    2. THERMO FISHER SCIENTIFIC INC.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    3. STADA ARZNEIMITTEL AG
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    4. sonic healthcare
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    5. Illumina, Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    6. AB-Biotics, S.A.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    7. ALTHEADX
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    8. CORIELL LIFE SCIENCES
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    9. luminex corporation
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    10. mydna life australia pty ltd.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    11. PerkinElmer Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    12. R-Biopharm AG
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
  19. questionnaire
  20. related reports

List of Table

TABLE 1 EUROPE PHARMACOGENETIC TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY TYPE, 2019-2028 (USD million)

TABLE 2 EUROPE PHARMACOGENETIC TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY GENES, 2019-2028 (USD million)

TABLE 3 EUROPE PHARMACOGENETIC TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 4 EUROPE PHARMACOGENETIC TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY SAMPLE TYPE, 2019-2028 (USD MILLION)

TABLE 5 EUROPE PHARMACOGENETIC TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 6 EUROPE PHARMACOGENETIC TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 7 EUROPE PHARMACOGENETIC TESTING IN PSYCHIATRY/DEPRESSION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 8 Europe pharmacogenetic testing in psychiatry/depression Market, By COUNTRY, 2019-2028 (USD MILLION)

TABLE 9 Europe pharmacogenetic testing in psychiatry/depression Market, By type, 2019-2028 (USD MILLION)

TABLE 10 Europe pharmacogenetic testing in psychiatry/depression Market, By genes, 2019-2028 (USD MILLION)

TABLE 11 Europe pharmacogenetic testing in psychiatry/depression Market, By drug type, 2019-2028 (USD MILLION)

TABLE 12 Europe pharmacogenetic testing in psychiatry/depression Market, By sample, 2019-2028 (USD MILLION)

TABLE 13 Europe pharmacogenetic testing in psychiatry/depression Market, By application, 2019-2028 (USD MILLION)

TABLE 14 Europe pharmacogenetic testing in psychiatry/depression Market, By end user, 2019-2028 (USD MILLION)

TABLE 15 Europe pharmacogenetic testing in psychiatry/depression Market, By distribution channel, 2019-2028 (USD MILLION)

TABLE 16 u.k. pharmacogenetic testing in psychiatry/depression Market, By type, 2019-2028 (USD MILLION)

TABLE 17 u.k. pharmacogenetic testing in psychiatry/depression Market, By genes, 2019-2028 (USD MILLION)

TABLE 18 u.k. pharmacogenetic testing in psychiatry/depression Market, By drug type, 2019-2028 (USD MILLION)

TABLE 19 u.k. pharmacogenetic testing in psychiatry/depression Market, By sample, 2019-2028 (USD MILLION)

TABLE 20 u.k. pharmacogenetic testing in psychiatry/depression Market, By application, 2019-2028 (USD MILLION)

TABLE 21 u.k. pharmacogenetic testing in psychiatry/depression Market, By end user, 2019-2028 (USD MILLION)

TABLE 22 u.k. pharmacogenetic testing in psychiatry/depression Market, By distribution channel, 2019-2028 (USD MILLION)

TABLE 23 germany pharmacogenetic testing in psychiatry/depression Market, By type, 2019-2028 (USD MILLION)

TABLE 24 germany pharmacogenetic testing in psychiatry/depression Market, By genes, 2019-2028 (USD MILLION)

TABLE 25 germany pharmacogenetic testing in psychiatry/depression Market, By drug type, 2019-2028 (USD MILLION)

TABLE 26 germany pharmacogenetic testing in psychiatry/depression Market, By sample, 2019-2028 (USD MILLION)

TABLE 27 germany pharmacogenetic testing in psychiatry/depression Market, By application, 2019-2028 (USD MILLION)

TABLE 28 germany pharmacogenetic testing in psychiatry/depression Market, By end user, 2019-2028 (USD MILLION)

TABLE 29 germany pharmacogenetic testing in psychiatry/depression Market, By distribution channel, 2019-2028 (USD MILLION)

TABLE 30 france pharmacogenetic testing in psychiatry/depression Market, By type, 2019-2028 (USD MILLION)

TABLE 31 france pharmacogenetic testing in psychiatry/depression Market, By genes, 2019-2028 (USD MILLION)

TABLE 32 france pharmacogenetic testing in psychiatry/depression Market, By drug type, 2019-2028 (USD MILLION)

TABLE 33 france pharmacogenetic testing in psychiatry/depression Market, By sample, 2019-2028 (USD MILLION)

TABLE 34 france pharmacogenetic testing in psychiatry/depression Market, By application, 2019-2028 (USD MILLION)

TABLE 35 france pharmacogenetic testing in psychiatry/depression Market, By end user, 2019-2028 (USD MILLION)

TABLE 36 france pharmacogenetic testing in psychiatry/depression Market, By distribution channel, 2019-2028 (USD MILLION)

TABLE 37 italy pharmacogenetic testing in psychiatry/depression Market, By type, 2019-2028 (USD MILLION)

TABLE 38 italy pharmacogenetic testing in psychiatry/depression Market, By genes, 2019-2028 (USD MILLION)

TABLE 39 italy pharmacogenetic testing in psychiatry/depression Market, By drug type, 2019-2028 (USD MILLION)

TABLE 40 italy pharmacogenetic testing in psychiatry/depression Market, By sample, 2019-2028 (USD MILLION)

TABLE 41 italy pharmacogenetic testing in psychiatry/depression Market, By application, 2019-2028 (USD MILLION)

TABLE 42 italy pharmacogenetic testing in psychiatry/depression Market, By end user, 2019-2028 (USD MILLION)

TABLE 43 italy pharmacogenetic testing in psychiatry/depression Market, By distribution channel, 2019-2028 (USD MILLION)

TABLE 44 spain pharmacogenetic testing in psychiatry/depression Market, By type, 2019-2028 (USD MILLION)

TABLE 45 spain pharmacogenetic testing in psychiatry/depression Market, By genes, 2019-2028 (USD MILLION)

TABLE 46 spain pharmacogenetic testing in psychiatry/depression Market, By drug type, 2019-2028 (USD MILLION)

TABLE 47 spain pharmacogenetic testing in psychiatry/depression Market, By sample, 2019-2028 (USD MILLION)

TABLE 48 spain pharmacogenetic testing in psychiatry/depression Market, By application, 2019-2028 (USD MILLION)

TABLE 49 spain pharmacogenetic testing in psychiatry/depression Market, By end user, 2019-2028 (USD MILLION)

TABLE 50 spain pharmacogenetic testing in psychiatry/depression Market, By distribution channel, 2019-2028 (USD MILLION)

TABLE 51 netherlands pharmacogenetic testing in psychiatry/depression Market, By type, 2019-2028 (USD MILLION)

TABLE 52 netherlands pharmacogenetic testing in psychiatry/depression Market, By genes, 2019-2028 (USD MILLION)

TABLE 53 netherlands pharmacogenetic testing in psychiatry/depression Market, By drug type, 2019-2028 (USD MILLION)

TABLE 54 netherlands pharmacogenetic testing in psychiatry/depression Market, By sample, 2019-2028 (USD MILLION)

TABLE 55 netherlands pharmacogenetic testing in psychiatry/depression Market, By application, 2019-2028 (USD MILLION)

TABLE 56 netherlands pharmacogenetic testing in psychiatry/depression Market, By end user, 2019-2028 (USD MILLION)

TABLE 57 netherlands pharmacogenetic testing in psychiatry/depression Market, By distribution channel, 2019-2028 (USD MILLION)

TABLE 58 belgium pharmacogenetic testing in psychiatry/depression Market, By type, 2019-2028 (USD MILLION)

TABLE 59 belgium pharmacogenetic testing in psychiatry/depression Market, By genes, 2019-2028 (USD MILLION)

TABLE 60 belgium pharmacogenetic testing in psychiatry/depression Market, By drug type, 2019-2028 (USD MILLION)

TABLE 61 belgium pharmacogenetic testing in psychiatry/depression Market, By sample, 2019-2028 (USD MILLION)

TABLE 62 belgium pharmacogenetic testing in psychiatry/depression Market, By application, 2019-2028 (USD MILLION)

TABLE 63 belgium pharmacogenetic testing in psychiatry/depression Market, By end user, 2019-2028 (USD MILLION)

TABLE 64 belgium pharmacogenetic testing in psychiatry/depression Market, By distribution channel, 2019-2028 (USD MILLION)

TABLE 65 russia pharmacogenetic testing in psychiatry/depression Market, By type, 2019-2028 (USD MILLION)

TABLE 66 russia pharmacogenetic testing in psychiatry/depression Market, By genes, 2019-2028 (USD MILLION)

TABLE 67 russia pharmacogenetic testing in psychiatry/depression Market, By drug type, 2019-2028 (USD MILLION)

TABLE 68 russia pharmacogenetic testing in psychiatry/depression Market, By sample, 2019-2028 (USD MILLION)

TABLE 69 russia pharmacogenetic testing in psychiatry/depression Market, By application, 2019-2028 (USD MILLION)

TABLE 70 russia pharmacogenetic testing in psychiatry/depression Market, By end user, 2019-2028 (USD MILLION)

TABLE 71 russia pharmacogenetic testing in psychiatry/depression Market, By distribution channel, 2019-2028 (USD MILLION)

TABLE 72 switzerland pharmacogenetic testing in psychiatry/depression Market, By type, 2019-2028 (USD MILLION)

TABLE 73 switzerland pharmacogenetic testing in psychiatry/depression Market, By genes, 2019-2028 (USD MILLION)

TABLE 74 switzerland pharmacogenetic testing in psychiatry/depression Market, By drug type, 2019-2028 (USD MILLION)

TABLE 75 switzerland pharmacogenetic testing in psychiatry/depression Market, By sample, 2019-2028 (USD MILLION)

TABLE 76 switzerland pharmacogenetic testing in psychiatry/depression Market, By application, 2019-2028 (USD MILLION)

TABLE 77 switzerland pharmacogenetic testing in psychiatry/depression Market, By end user, 2019-2028 (USD MILLION)

TABLE 78 switzerland pharmacogenetic testing in psychiatry/depression Market, By distribution channel, 2019-2028 (USD MILLION)

TABLE 79 turkey pharmacogenetic testing in psychiatry/depression Market, By type, 2019-2028 (USD MILLION)

TABLE 80 turkey pharmacogenetic testing in psychiatry/depression Market, By genes, 2019-2028 (USD MILLION)

TABLE 81 turkey pharmacogenetic testing in psychiatry/depression Market, By drug type, 2019-2028 (USD MILLION)

TABLE 82 turkey pharmacogenetic testing in psychiatry/depression Market, By sample, 2019-2028 (USD MILLION)

TABLE 83 turkey pharmacogenetic testing in psychiatry/depression Market, By application, 2019-2028 (USD MILLION)

TABLE 84 turkey pharmacogenetic testing in psychiatry/depression Market, By end user, 2019-2028 (USD MILLION)

TABLE 85 turkey pharmacogenetic testing in psychiatry/depression Market, By distribution channel, 2019-2028 (USD MILLION)

TABLE 86 rest of Europe pharmacogenetic testing in psychiatry/depression Market, By type, 2019-2028 (USD MILLION)

List of Figure

FIGURE 1 Europe PHARMACOGENETIC TESTInG IN PSYCHIATRY/DEPRESSION market: segmentation

FIGURE 2 Europe pharmacogenetic testing in psychiatric/depression market: data triangulation

FIGURE 3 Europe PHARMACOGENETIC TESTING IN PSYCHIATRIC/DEPRESSION market: DROC ANALYSIS

FIGURE 4 Europe PHARMACOGENETIC TESTING IN PSYCHIATRIC/DEPRESSION market: Region vs country MARKET ANALYSIS

FIGURE 5 Europe PHARMACOGENETIC TESTING IN PSYCHIATRIC/DEPRESSION market: COMPANY RESEARCH ANALYSIS

FIGURE 6 Europe pharmacogenetic testing in psychiatric/depression market: DBMR MARKET POSITION GRID

FIGURE 7 Europe pharmacogenetic testing in psychiatry/depression market: MARKET APPLICATION COVERAGE GRID

FIGURE 8 Europe pharmacogenetic testing in psychiatry/depression market: vendor share analysis

FIGURE 9 Europe pharmacogenetic testing in psychiatry/depression market: SEGMENTATION

FIGURE 10 initiatives taken by manufacturers is expected to drive THE Europe pharmacogenetic testing in psychiatry/depression market IN THE FORECAST PERIOD of 2021 to 2028

FIGURE 11 whole genome sequencing segment is expected to account for the largest share of the Europe pharmacogenetic testing in psychiatry/depression market in 2021 & 2028

FIGURE 12 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF EUROPE PHARMACOGENETIC TESTING IN PSYCHIATRY/DEPRESSION MARKET

FIGURE 13 EUROPE PHARMACOGENETIC TESTING IN PSYCHIATRY/DEPRESSION MARKET: BY TYPE, 2020

FIGURE 14 EUROPE PHARMACOGENETIC TESTING IN PSYCHIATRY/DEPRESSION MARKET: BY TYPE, 2019-2028 (USD MILLION)

FIGURE 15 EUROPE PHARMACOGENETIC TESTING IN PSYCHIATRY/DEPRESSION MARKET: BY TYPE, CAGR (2021-2028)

FIGURE 16 EUROPE PHARMACOGENETIC TESTING IN PSYCHIATRY/DEPRESSION MARKET: BY TYPE, LIFELINE CURVE

FIGURE 17 EUROPE PHARMACOGENETIC TESTING IN PSYCHIATRY/DEPRESSION MARKET: BY GENES, 2020

FIGURE 18 EUROPE PHARMACOGENETIC TESTING IN PSYCHIATRY/DEPRESSION MARKET: BY GENES, 2019-2028 (USD MILLION)

FIGURE 19 EUROPE PHARMACOGENETIC TESTING IN PSYCHIATRY/DEPRESSION MARKET: BY GENES, CAGR (2021-2028)

FIGURE 20 EUROPE PHARMACOGENETIC TESTING IN PSYCHIATRY/DEPRESSION MARKET: BY GENES, LIFELINE CURVE

FIGURE 21 EUROPE PHARMACOGENETIC TESTING IN PSYCHIATRY/DEPRESSION MARKET: BY DRUG TYPE, 2020

FIGURE 22 EUROPE PHARMACOGENETIC TESTING IN PSYCHIATRY/DEPRESSION MARKET: BY DRUG TYPE, 2019-2028 (USD MILLION)

FIGURE 23 EUROPE PHARMACOGENETIC TESTING IN PSYCHIATRY/DEPRESSION MARKET: BY DRUG TYPE, CAGR (2021-2028)

FIGURE 24 EUROPE PHARMACOGENETIC TESTING IN PSYCHIATRY/DEPRESSION MARKET: BY DRUG TYPE, LIFELINE CURVE

FIGURE 25 EUROPE PHARMACOGENETIC TESTING IN PSYCHIATRY/DEPRESSION MARKET: BY SAMPLE TYPE, 2020

FIGURE 26 EUROPE PHARMACOGENETIC TESTING IN PSYCHIATRY/DEPRESSION MARKET: BY SAMPLE TYPE, 2019-2028 (USD MILLION)

FIGURE 27 EUROPE PHARMACOGENETIC TESTING IN PSYCHIATRY/DEPRESSION MARKET: BY DRUG TYPE, CAGR (2021-2028)

FIGURE 28 EUROPE PHARMACOGENETIC TESTING IN PSYCHIATRY/DEPRESSION MARKET: BY SAMPLE TYPE, LIFELINE CURVE

FIGURE 29 EUROPE PHARMACOGENETIC TESTING IN PSYCHIATRY/DEPRESSION MARKET: BY APPLICATION, 2020

FIGURE 30 EUROPE PHARMACOGENETIC TESTING IN PSYCHIATRY/DEPRESSION MARKET: BY APPLICATION, 2019-2028 (USD MILLION)

FIGURE 31 EUROPE PHARMACOGENETIC TESTING IN PSYCHIATRY/DEPRESSION MARKET: BY APPLICATION, CAGR (2021-2028)

FIGURE 32 EUROPE PHARMACOGENETIC TESTING IN PSYCHIATRY/DEPRESSION MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 33 EUROPE PHARMACOGENETIC TESTING IN PSYCHIATRY/DEPRESSION MARKET: BY END USER, 2020

FIGURE 34 EUROPE PHARMACOGENETIC TESTING IN PSYCHIATRY/DEPRESSION MARKET: BY END USER, 2019-2028 (USD MILLION)

FIGURE 35 EUROPE PHARMACOGENETIC TESTING IN PSYCHIATRY/DEPRESSION MARKET: BY END USER, CAGR (2021-2028)

FIGURE 36 EUROPE PHARMACOGENETIC TESTING IN PSYCHIATRY/DEPRESSION MARKET: BY END USER, LIFELINE CURVE

FIGURE 37 EUROPE PHARMACOGENETIC TESTING IN PSYCHIATRY/DEPRESSION MARKET: BY DISTRIBUTION CHANNEL, 2020

FIGURE 38 EUROPE PHARMACOGENETIC TESTING IN PSYCHIATRY/DEPRESSION MARKET: BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

FIGURE 39 EUROPE PHARMACOGENETIC TESTING IN PSYCHIATRY/DEPRESSION MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)

FIGURE 40 EUROPE PHARMACOGENETIC TESTING IN PSYCHIATRY/DEPRESSION MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 41 Europe PHARMACOGENETIC TESTING IN PSYCHIATRY/DEPRESSION MARKET: SNAPSHOT (2020)

FIGURE 42 Europe PHARMACOGENETIC TESTING IN PSYCHIATRY/DEPRESSION MARKET: BY COUNTRY (2020)

FIGURE 43 Europe PHARMACOGENETIC TESTING IN PSYCHIATRY/DEPRESSION MARKET: BY COUNTRY (2021 & 2028)

FIGURE 44 Europe PHARMACOGENETIC TESTING IN PSYCHIATRY/DEPRESSION MARKET: BY COUNTRY (2020 & 2028)

FIGURE 45 Europe PHARMACOGENETIC TESTING IN PSYCHIATRY/DEPRESSION MARKET: BY type (2021-2028)

FIGURE 46 Europe pharmacogenetic testing in psychiatry/depression Market: company share 2020 (%)

Browse Related Pages

Banner